Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Acta Pharmaceutica
Volume 60 (2010): Issue 4 (December 2010)
Open Access
Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses
Septimiu Bucurescu
Septimiu Bucurescu
| Dec 17, 2010
Acta Pharmaceutica
Volume 60 (2010): Issue 4 (December 2010)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 17, 2010
Page range:
407 - 413
DOI:
https://doi.org/10.2478/v10007-010-0039-2
Keywords
terapija karcinoma
,
glikoproteini E i I
,
Herpes simplex virusa tipa 1
,
neutralizacija onkolitskih virusa posredovana antitijelima
This content is open access.
Septimiu Bucurescu
»Rhoen Klinikum AG« Hospital, 97616 Bad Neustadt ad Saale, Germany